Skip to content
10-Q

Quarterly Report

ROCK CREEK PHARMACEUTICALS, INC.

0001144204-15-063861

← back to feed
Filed
Nov 9, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2015 · Nov 5, 2015 11.24M sh
Capex Q3 2015 · Sep 30, 2015 $8K
Capex Q3 2015 · Sep 30, 2014 $211K
Long Term Debt Q3 2015 · Sep 30, 2015 $350K
Long Term Debt Q3 2015 · Dec 31, 2014 $350K
Cash And Equivalents Q3 2015 · Sep 30, 2015 $146K
Cash And Equivalents Q3 2015 · Dec 31, 2014 $395K
Cash And Equivalents Q3 2015 · Sep 30, 2014 $2.67M
Cash And Equivalents Q3 2015 · Dec 31, 2013 $3.88M
Stockholders Equity Q3 2015 · Sep 30, 2015 −$9.5M
Stockholders Equity Q3 2015 · Dec 31, 2014 −$10.84M
Current Liabilities Q3 2015 · Sep 30, 2015 $11.18M
Current Liabilities Q3 2015 · Dec 31, 2014 $19.4M
Total Liabilities Q3 2015 · Sep 30, 2015 $11.53M
Total Liabilities Q3 2015 · Dec 31, 2014 $19.75M
Current Assets Q3 2015 · Sep 30, 2015 $996K
Current Assets Q3 2015 · Dec 31, 2014 $7.8M
Total Assets Q3 2015 · Sep 30, 2015 $2.03M
Total Assets Q3 2015 · Dec 31, 2014 $8.92M
Sga Expense Q3 2015 · Sep 30, 2015 $2.23M
Sga Expense Q3 2015 · Sep 30, 2015 $7.22M
Sga Expense Q3 2015 · Sep 30, 2014 $4.32M
Sga Expense Q3 2015 · Sep 30, 2014 $24.47M
Rd Expense Q3 2015 · Sep 30, 2015 $1.27M
Rd Expense Q3 2015 · Sep 30, 2015 $2.12M
Rd Expense Q3 2015 · Sep 30, 2014 $1.69M
Rd Expense Q3 2015 · Sep 30, 2014 $3.19M
Net Income Q3 2015 · Sep 30, 2015 −$2.84M
Net Income Q3 2015 · Sep 30, 2015 −$4.02M
Net Income Q3 2015 · Sep 30, 2014 −$10.04M
Net Income Q3 2015 · Sep 30, 2014 −$32.58M
Operating Income Q3 2015 · Sep 30, 2015 −$3.5M
Operating Income Q3 2015 · Sep 30, 2015 −$9.34M
Operating Income Q3 2015 · Sep 30, 2014 −$6.01M
Operating Income Q3 2015 · Sep 30, 2014 −$27.66M